{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T21:33:48Z","timestamp":1762032828317},"reference-count":33,"publisher":"Elsevier BV","issue":"35","license":[{"start":{"date-parts":[[2009,7,1]],"date-time":"2009-07-01T00:00:00Z","timestamp":1246406400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2009,7]]},"DOI":"10.1016\/j.vaccine.2009.05.065","type":"journal-article","created":{"date-parts":[[2009,6,12]],"date-time":"2009-06-12T12:59:29Z","timestamp":1244811569000},"page":"4850-4856","source":"Crossref","is-referenced-by-count":27,"title":["Randomized placebo controlled human volunteer trial of a live oral cholera vaccine VA1.3 for safety and immune response"],"prefix":"10.1016","volume":"27","author":[{"given":"D.","family":"Mahalanabis","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.","family":"Ramamurthy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.B.","family":"Nair","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Ghosh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Shaikh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.","family":"Sen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Thungapathra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.K.","family":"Ghosh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.P.","family":"Pazhani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.K.","family":"Nandy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Jana","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.K.","family":"Bhattacharya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2009.05.065_bib1","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/S0140-6736(88)90120-1","article-title":"Safety, immunogenicity, and efficacy of recombinant live oral cholera vaccines, CVD 103 and CVD 103-HgR","volume":"2","author":"Levine","year":"1988","journal-title":"Lancet"},{"issue":"8","key":"10.1016\/j.vaccine.2009.05.065_bib2","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1056\/NEJMoa043323","article-title":"Effectiveness of mass oral cholera vaccination in Beira, Mozambique","volume":"352 (8):757\u201367","author":"Lucas","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2009.05.065_bib3","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/S0140-6736(96)06107-7","article-title":"Field trial of a locally produced, killed, oral cholera vaccine in Viet Nam","volume":"349","author":"Trach","year":"1997","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2009.05.065_bib4","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/S0165-2478(99)00076-0","article-title":"Construction of a recombinant live oral vaccine from a non-toxigenic strain of Vibrio cholerae O1 serotype inaba biotype E1 Tor and assessment of its reactogenicity and immunogenicity in the rabbit model","volume":"68","author":"Thungapathra","year":"1999","journal-title":"Immunol Lett"},{"issue":"6","key":"10.1016\/j.vaccine.2009.05.065_bib5","doi-asserted-by":"crossref","first-page":"e2323","DOI":"10.1371\/journal.pone.0002323","article-title":"A randomized, placebo-controlled trial of the bivalent killed, whole-cell, oral cholera vaccine in adults and children in a cholera endemic area in Kolkata, India","volume":"3","author":"Mahalanabis","year":"2008","journal-title":"PloS One"},{"key":"10.1016\/j.vaccine.2009.05.065_bib6","first-page":"277","article-title":"Serological studies in cholera. 2. The vibriocidal antibody response of cholera patients determined by a microtechnique","volume":"38","author":"Benenson","year":"1968","journal-title":"Bull WHO"},{"key":"10.1016\/j.vaccine.2009.05.065_bib7","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1016\/0264-410X(96)00035-7","article-title":"Serum antibacterial and antitoxin responses clinical cholera caused by Vibrio cholerae O139 Bengal and evaluation of their importance in protection","volume":"14","author":"Nandy","year":"1996","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2009.05.065_bib8","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/0014-5793(93)81136-N","article-title":"Identification of toxigenic Vibrio cholerae from the Argentine outbreak by PCR for ctx A1 and ctx A2-B","volume":"315","author":"Varela","year":"1993","journal-title":"FEBS Lett"},{"key":"10.1016\/j.vaccine.2009.05.065_bib9","doi-asserted-by":"crossref","first-page":"3261","DOI":"10.1128\/IAI.57.11.3261-3264.1989","article-title":"Preliminary assessment of the safety and immunogenicity of live oral cholera vaccine strain CVD 103-HgR in healthy Thai adults","volume":"57","author":"Migasena","year":"1989","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2009.05.065_bib10","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1093\/infdis\/165.6.1042","article-title":"Safety and immunogenicity of different immunization regimens of CVD 103-HgR live oral cholera vaccine in soldiers and civilians in Thailand","volume":"165","author":"Su-Arehawaratana","year":"1992","journal-title":"J Infect Dis"},{"issue":"22","key":"10.1016\/j.vaccine.2009.05.065_bib11","doi-asserted-by":"crossref","first-page":"2399","DOI":"10.1016\/S0264-410X(00)00006-2","article-title":"Efficacy trial of single-dose live oral cholera vaccine CVD 103-HgR in North Jakarta, Indonesia, a cholera-endemic area","volume":"18","author":"Richie","year":"2000","journal-title":"Vaccine"},{"issue":"2","key":"10.1016\/j.vaccine.2009.05.065_bib12","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.vaccine.2006.08.031","article-title":"Peru-15, a live attenuated oral cholera vaccine, is safe and immunogenic in Bangladeshi toddlers and infants","volume":"25","author":"Qadri","year":"2007","journal-title":"Vaccine"},{"issue":"4","key":"10.1016\/j.vaccine.2009.05.065_bib13","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1086\/432074","article-title":"Randomized, controlled study of the safety and immunogenicity of Peru-15, a live attenuated oral vaccine candidate for cholera, in adult volunteers in Bangladesh","volume":"192","author":"Qadri","year":"2005","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2009.05.065_bib14","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1086\/514025","article-title":"Evaluation of Peru-15, a new live oral vaccine for cholera, in volunteers","volume":"176","author":"Sack","year":"1997","journal-title":"J Infect Dis"},{"issue":"2","key":"10.1016\/j.vaccine.2009.05.065_bib15","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1128\/IAI.67.2.539-545.1999","article-title":"Preliminary assessment of the safety and immunogenicity of a new CTXPhi-negative, hemagglutinin\/protease-defective El Tor strain as a cholera vaccine candidate","volume":"67","author":"Ben\u00edtez","year":"1999","journal-title":"Infect Immun"},{"issue":"5","key":"10.1016\/j.vaccine.2009.05.065_bib16","doi-asserted-by":"crossref","first-page":"3018","DOI":"10.1128\/IAI.73.5.3018-3024.2005","article-title":"The vaccine candidate Vibrio cholerae 638 is protective against cholera in healthy volunteers","volume":"73","author":"Garc\u00eda","year":"2005","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2009.05.065_bib17","first-page":"777","article-title":"The relationship of vibriocidal antibody titre to susceptibility to cholera in family contacts of cholera patients","volume":"38","author":"Mosley","year":"1968","journal-title":"Bull World Health Organ"},{"key":"10.1016\/j.vaccine.2009.05.065_bib18","first-page":"327","article-title":"A serological survey for cholear antibodies in rural east Pakistan 1. The distribution of antibody in the control population of a cholera-vaccine field-trial area and the relation of antibody titre to the pattern of endemic cholera","volume":"38","author":"Mosley","year":"1968","journal-title":"Bull World Health Organ"},{"key":"10.1016\/j.vaccine.2009.05.065_bib19","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1128\/JB.100.1.547-549.1969","article-title":"Active and passive immunization in the adult rabbit ileal loop model as an assay for production of antitoxin immunity by cholera vaccines","volume":"100","author":"Mosley","year":"1969","journal-title":"J Bacteriol"},{"key":"10.1016\/j.vaccine.2009.05.065_bib20","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1093\/infdis\/151.2.236","article-title":"Seroepidemiological studies of El Tor cholera in Bangladesh: association of serum antibody levels with protection","volume":"151","author":"Glass","year":"1985","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2009.05.065_bib21","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1093\/infdis\/163.6.1235","article-title":"Field trial of oral cholera vaccines in Bangladesh: serum vibriocidal and antitoxic antibodies as markers of the risk of cholera","volume":"163","author":"Clemens","year":"1991","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2009.05.065_bib22","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/0264-410X(93)90019-T","article-title":"Live oral vaccines against cholera: an update","volume":"11","author":"Levine","year":"1993","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2009.05.065_bib23","series-title":"Cholera","first-page":"285","article-title":"Immunity and vaccine development","author":"Levine","year":"1992"},{"key":"10.1016\/j.vaccine.2009.05.065_bib24","doi-asserted-by":"crossref","first-page":"2318","DOI":"10.1086\/421275","article-title":"Incomplete correlation of serum vibriocidal antibody titer with protection from Vibrio cholerae infection in urban Bangladesh","volume":"189","author":"Saha","year":"2004","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2009.05.065_bib25","doi-asserted-by":"crossref","first-page":"4211","DOI":"10.1128\/JCM.01304-06","article-title":"Cholera due to altered El Tor strains of Vibrio cholerae O1 in Bangladesh","volume":"44","author":"Nair","year":"2006","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.vaccine.2009.05.065_bib26","doi-asserted-by":"crossref","first-page":"131","DOI":"10.3201\/eid1501.080543","article-title":"Changes in Vibrio cholerae O1 biotypes, Kolkata, India","volume":"15","author":"Raychoudhuri","year":"2009","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.vaccine.2009.05.065_bib27","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1099\/jmm.0.46689-0","article-title":"Genetic characteristics of Matlab variants of Vibrio cholerae O1 that are hybrids between classical and El Tor biotypes","volume":"55","author":"Safa","year":"2006","journal-title":"J Med Microbiol"},{"key":"10.1016\/j.vaccine.2009.05.065_bib28","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1080\/03014467700002481","article-title":"ABO blood groups and cholera","volume":"4","author":"Barua","year":"1977","journal-title":"Ann Hum Biol"},{"key":"10.1016\/j.vaccine.2009.05.065_bib29","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1016\/0035-9203(78)90031-7","article-title":"Possible role of blood-group secretory substances in the aetiology of cholera","volume":"72","author":"Chaudhuri","year":"1978","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"10.1016\/j.vaccine.2009.05.065_bib30","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1093\/infdis\/159.4.770","article-title":"ABO blood groups and cholera: new observations on specificity of risk and modification of vaccine efficacy","volume":"159","author":"Clemens","year":"1989","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2009.05.065_bib31","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1093\/clinids\/18.5.827","article-title":"The relationship between ABO blood groups and susceptibility to diarrhea due to Vibrio cholerae O139","volume":"18","author":"Faruque","year":"1994","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2009.05.065_bib32","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1093\/infdis\/170.2.468","article-title":"Severe life-threatening cholera associated with blood group O in Peru; implications for the Latin American epidemic","volume":"170","author":"Swerdlow","year":"1994","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2009.05.065_bib33","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1093\/oxfordjournals.aje.a114050","article-title":"Predisposition for cholera of individuals with O blood group. Possible evolutionary significance","volume":"121","author":"Glass","year":"1985","journal-title":"Am J Epidemiol"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X09007804?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X09007804?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,5,19]],"date-time":"2020-05-19T16:13:13Z","timestamp":1589904793000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X09007804"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,7]]},"references-count":33,"journal-issue":{"issue":"35","published-print":{"date-parts":[[2009,7]]}},"alternative-id":["S0264410X09007804"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2009.05.065","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2009,7]]}}}